Fortress Biotech (NASDAQ:FBIO) – B. Riley issued their FY2019 EPS estimates for shares of Fortress Biotech in a research report issued on Wednesday, December 18th. B. Riley analyst M. Mamtani forecasts that the biopharmaceutical company will post earnings per share of ($0.80) for the year. B. Riley currently has a “Buy” rating and a $9.00 target price on the stock. B. Riley also issued estimates for Fortress Biotech’s FY2021 earnings at ($1.09) EPS, FY2022 earnings at $1.42 EPS and FY2023 earnings at $3.48 EPS.

Occidental Petroleum Co. (NYSE:OXY) – Investment analysts at Capital One Financial lowered their FY2019 earnings estimates for Occidental Petroleum in a research note issued on Wednesday, December 18th. Capital One Financial analyst R. Tullis now anticipates that the oil and gas producer will post earnings of $1.77 per share for the year, down from their previous estimate of $2.14. Capital One Financial also issued estimates for Occidental Petroleum’s Q4 2019 earnings at ($0.15) EPS and FY2020 earnings at $1.87 EPS.

SilverCrest Metals Inc. (NASDAQ:SILV) – Research analysts at B. Riley lowered their FY2021 earnings estimates for shares of SilverCrest Metals in a report released on Thursday, December 5th, according to Zacks Investment Research. B. Riley analyst A. Graf now anticipates that the company will post earnings per share of ($0.04) for the year, down from their previous forecast of ($0.03). B. Riley has a “Neutral” rating on the stock.

TCF Financial Co. (NYSE:TCF) – Wedbush dropped their Q4 2019 earnings estimates for TCF Financial in a research report issued to clients and investors on Friday, December 20th. Wedbush analyst D. Chiaverini now expects that the bank will post earnings of $0.99 per share for the quarter, down from their prior estimate of $1.01. Wedbush also issued estimates for TCF Financial’s Q3 2020 earnings at $1.09 EPS.

BEST Inc. (NYSE:BEST) – Stock analysts at Jefferies Financial Group issued their FY2019 earnings per share estimates for BEST in a research note issued to investors on Wednesday, December 4th, according to Zacks Investment Research. Jefferies Financial Group analyst T. Chong expects that the company will post earnings per share of ($0.06) for the year. Jefferies Financial Group currently has a “Buy” rating and a $7.40 target price on the stock. Jefferies Financial Group also issued estimates for BEST’s FY2020 earnings at $0.05 EPS.

Marinus Pharmaceuticals Inc (NASDAQ:MRNS) – Equities researchers at Oppenheimer issued their FY2021 earnings per share estimates for shares of Marinus Pharmaceuticals in a research note issued on Thursday, December 19th. Oppenheimer analyst J. Olson expects that the biopharmaceutical company will earn ($0.50) per share for the year. Oppenheimer has a “Outperform” rating and a $6.00 price objective on the stock.

Phillips 66 (NYSE:PSX) – Jefferies Financial Group raised their FY2019 earnings estimates for shares of Phillips 66 in a research note issued on Wednesday, December 18th. Jefferies Financial Group analyst C. Sighinolfi now expects that the oil and gas company will post earnings of $9.13 per share for the year, up from their previous forecast of $8.58. Jefferies Financial Group also issued estimates for Phillips 66’s Q1 2020 earnings at $1.87 EPS, Q3 2020 earnings at $2.98 EPS, Q4 2020 earnings at $2.98 EPS, FY2020 earnings at $10.81 EPS, FY2021 earnings at $9.45 EPS, FY2022 earnings at $8.98 EPS and FY2023 earnings at $10.13 EPS.

Jefferies Financial Group lowered shares of Synthorx (NASDAQ:THOR) from a buy rating to a hold rating in a research note published on Thursday, BenzingaRatingsTable reports. The firm currently has $68.00 price target on the medical instruments supplier’s stock, up from their previous price target of $23.00.

Jefferies Financial Group began coverage on shares of ManpowerGroup (NYSE:MAN) in a report issued on Wednesday, November 27th, Benzinga reports. The firm issued a hold rating and a $96.00 price target on the business services provider’s stock.

Nike (NYSE:NKE)‘s stock had its “neutral” rating reaffirmed by equities researchers at Jefferies Financial Group in a research note issued on Friday, Borsen Zeitung reports. They presently have a $97.00 price target on the footwear maker’s stock. Jefferies Financial Group’s price target indicates a potential downside of 2.96% from the stock’s current price. Jefferies Financial Group also issued estimates for Nike’s Q3 2020 earnings at $0.68 EPS and FY2020 earnings at $3.00 EPS.